Industry Updates for the Psychedelics World | Page 30 of 35

Psychedelics News

Industry

17 Mar 2022

Awakn Life Sciences Announces New Clinic: A Closer Look

With two advanced Phase 2 studies underway (using both ketamine and MDMA for alcohol addiction) Awakn has quietly put itself in the top tier of companies in terms of clinical...

By Jason Najum

Industry

16 Mar 2022

Novamind to Host MindMed’s Phase 2b Trial

Novamind will host the LSD Clinical Trial at its Draper, Utah research site, further strengthening its track record of hosting neuropsychiatry and psychedelic clinical trials....

By Microdose

Industry

15 Mar 2022

Is the UK Becoming a Global Center for Psychedelic Medicine?

With innovative companies and industry-leading research, as well as an increasingly favorable regulatory environment, it seems the United Kingdom is indeed positioning itself as a leading center for the psychedelic...

By Freddie Earlam

Industry

15 Mar 2022

Global Wellness Institute Announces New Psychedelics Initiative

The Initiative will support collaboration and coalition building, and ethics and best practices, in the psychedelic community....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

10 Mar 2022

Small Pharma Expands Clinical Trial Pipeline

Lead DMT-assisted therapy candidate SPL026’s clinical development program strengthened with the addition of two clinical trials planned for 2022...

By Microdose

Industry

8 Mar 2022

Seelos Therapeutics: Year-End Results and Business Highlights

Even if not on most people’s sexiest shroom stock list, Seelos Therapeutics has been a solid presence in the psychedelic medicine space for some time....

By Jason Najum

Industry

2 Mar 2022

MindMed Announces Study Comparing LSD and Psilocybin

Back in the spring of 2020, in the early days of the psychedelic medicine industry, MindMed signed one of the sector's most significant research collaborations....

By Jason Najum

Industry

1 Mar 2022

An Interview With Cybin CEO Doug Drysdale

We sat down with CEO Doug Drysdale to discuss these and other industry topics, including Cybin’s developmental pipeline, upcoming clinical trials, and the state of the psychedelic medicine market...

By Jason Najum

Breaking News, Industry

1 Mar 2022

Calgary-based Med Plant Science Ltd. granted license to research and develop psychedelics in St Vincent and the Grenadines

Calgary-based biotech company, Med Plant Science Ltd, has been awarded a license for medicinal plants containing psychedelic compounds by the St....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result